Skip to main content
SpringerLink
Log in

Coagulopathy and cannabinoids: what the radiologist should know

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

The Original Article was published on 21 December 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kelkar AH, Smith NA, Martial A, Moole H, Tarantino MD, Roberts JC (2018) An outbreak of synthetic cannabinoid-associated coagulopathy in Illinois. N Engl J Med 379(13):1216–1223. https://doi.org/10.1056/NEJMoa1807652

    Article  CAS  PubMed  Google Scholar 

  2. Arepally GM, Ortel TL (2019) Bad weed: synthetic cannabinoid-associated coagulopathy. Blood 133(9):902–905. https://doi.org/10.1182/blood-2018-11-876839

    Article  CAS  PubMed  Google Scholar 

  3. Bar N, Lopez-Alonso R, Merhav G et al (2023) Radiological findings in poisoning by synthetic cannabinoids adulterated with brodifacoum. Eur Radiol. https://doi.org/10.1007/s00330-023-10496-4

    Article  PubMed  Google Scholar 

  4. Fasih A (2021) Lethal coagulopathy resulting from the consumption of contaminated synthetic cannabinoids: the story of a public health crisis. J Public Health (Oxf) 43(1):e1–e6. https://doi.org/10.1093/pubmed/fdz067

    Article  PubMed  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

  1. Beaumont Hospital, Dublin, Ireland

    Aileen O’Shea

Authors
  1. Aileen O’Shea
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aileen O’Shea.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Aileen O’Shea.

Conflict of interest

The authors of this manuscript declare relationships with the following companies:

Radiologic Society of North America. Dr. O’Shea is an editorial board member for the journal, Radiology Advances.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was not required.

Ethical approval

Institutional Review Board approval was not required because no original research was performed.

Study subjects or cohorts overlap

N/A

Methodology

• commentary

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s00330-023-10496-4.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Shea, A. Coagulopathy and cannabinoids: what the radiologist should know. Eur Radiol (2023). https://doi.org/10.1007/s00330-023-10532-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00330-023-10532-3

Search

Navigation